A Prospective Randomized Clinical Trial to Validate Atrial Fibrillation Substrate Ablation for Non-Paroxysmal Atrial Fibrillation

Randomized controlled trial evaluating the safety and effectiveness of CARTOFINDER guided substrate ablation for non-paroxysmal AF. - Randomized controlled FINGER AF trial (FINder Guided sabstratE Radiofrequency catheter ablation for non-pAF)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051524

Enrollment

130

Registered

2023-07-05

Start date

2022-07-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

For initial catheter ablation of nonparoxysmal atrial fibrillation, patients will be randomized 1:1 to pulmonary vein isolation alone (Control group) or pulmonary vein isolation plus ablation of the a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for initial catheter ablation for non-paroxysmal atrial fibrillation and who have consented to the study

Exclusion criteria

Exclusion criteria: Previous cardiac surgery Patients who are considered unfit for follow-up NYHA 4th degree heart failure Atrial fibrillation due to reversible causes Contraindication to anticoagulation Pregnancy Other cases deemed inappropriate by the attending physician

Design outcomes

Primary

Measure	Time frame
Atrial fibrillation and tachycardia free rate	—

Secondary

Measure	Time frame
Adverse events related to ablation procedure, heart failure, ischemic stroke, cardiac death	—

Countries

Japan

Contacts

Public ContactNaoyuki Miwa

Tsuchiura Kyodo General Hospital Heart Rhythm Center

jet_stream0624@yahoo.co.jp029-830-3711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026